1. Home
  2. FEAM vs SYRS Comparison

FEAM vs SYRS Comparison

Compare FEAM & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEAM
  • SYRS
  • Stock Information
  • Founded
  • FEAM 2016
  • SYRS 2011
  • Country
  • FEAM United States
  • SYRS United States
  • Employees
  • FEAM 57
  • SYRS N/A
  • Industry
  • FEAM Major Chemicals
  • SYRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEAM Industrials
  • SYRS Health Care
  • Exchange
  • FEAM Nasdaq
  • SYRS Nasdaq
  • Market Cap
  • FEAM 44.6M
  • SYRS 52.5M
  • IPO Year
  • FEAM N/A
  • SYRS 2016
  • Fundamental
  • Price
  • FEAM $0.61
  • SYRS $1.94
  • Analyst Decision
  • FEAM Buy
  • SYRS Strong Buy
  • Analyst Count
  • FEAM 4
  • SYRS 3
  • Target Price
  • FEAM $4.19
  • SYRS $5.00
  • AVG Volume (30 Days)
  • FEAM 161.1K
  • SYRS 344.1K
  • Earning Date
  • FEAM 11-07-2024
  • SYRS 11-12-2024
  • Dividend Yield
  • FEAM N/A
  • SYRS N/A
  • EPS Growth
  • FEAM N/A
  • SYRS N/A
  • EPS
  • FEAM N/A
  • SYRS N/A
  • Revenue
  • FEAM N/A
  • SYRS $4,149,000.00
  • Revenue This Year
  • FEAM N/A
  • SYRS N/A
  • Revenue Next Year
  • FEAM $1,117.19
  • SYRS $614.29
  • P/E Ratio
  • FEAM N/A
  • SYRS N/A
  • Revenue Growth
  • FEAM N/A
  • SYRS N/A
  • 52 Week Low
  • FEAM $0.40
  • SYRS $1.43
  • 52 Week High
  • FEAM $3.24
  • SYRS $8.17
  • Technical
  • Relative Strength Index (RSI)
  • FEAM 53.57
  • SYRS 44.68
  • Support Level
  • FEAM $0.56
  • SYRS $1.93
  • Resistance Level
  • FEAM $0.75
  • SYRS $2.01
  • Average True Range (ATR)
  • FEAM 0.10
  • SYRS 0.12
  • MACD
  • FEAM 0.03
  • SYRS 0.06
  • Stochastic Oscillator
  • FEAM 61.62
  • SYRS 27.66

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About SYRS Syros Pharmaceuticals Inc.

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Share on Social Networks: